Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT00006008

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 71 locations
View Trial Details
Completed

Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation

NCT00737516

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • StemCyte International Cord Blood Center Covina, California, United States
  • Children's Hospital of Orange County Cord Blood Bank Orange, California, United States
  • Ashley Ross Cord Blood Program San Diego, California, United States
  • University of Colorado Cord Blood Bank Aurora, Colorado, United States
View all 19 locations
View Trial Details
Completed

Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

NCT00002471

Conditions
Burkitt Lymphoma, DNA Virus Infections, Dendritic Cell Sarcoma, Interdigitating, +22 more
Locations
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Kaplan Cancer Center New York, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Completed

506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

NCT00003837

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States
  • NCI - Pharmaceutical Management Branch Bethesda, Maryland, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details

Related conditions